Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

TGA Approval

TOLVAPTAN GH tolvaptan 30 mg + 60 mg tablet blister composite pack (417519)

ARTG ID

417519

ARTG Name

TOLVAPTAN GH tolvaptan 30 mg + 60 mg tablet blister composite pack

Sponsor

Lupin Australia Pty Limited

ARTG Date

October 30, 2024

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Lupin Australia Pty Limited

Sponsor Item Name

LUPIN AUSTRALIA PTY LIMITED

Active Ingredients

Ingredient Name

tolvaptan

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

TOLVAPTAN GH tolvaptan 30 mg + 60 mg tablet blister composite pack (417519) - TGA 批准文号 | MedPath